Euphoria Infotech (India) Ltd: Intrinsic Value & Share Price Analysis

Share Price and Basic Stock Data

Last Updated: November 28, 2025, 11:05 am

Competitors of Euphoria Infotech (India) Ltd

All Competitor Stocks of Euphoria Infotech (India) Ltd

Quarterly Result

Last Updated: May 31, 2025, 6:07 am

Below is a detailed analysis of the quarterly data for Euphoria Infotech (India) Ltd based on the most recent figures (Mar 2025) and their trends compared to the previous period:

• For Sales, as of Mar 2025, the value is 6.26 Cr.. The value appears to be declining and may need further review. It has decreased from 6.96 Cr. (Sep 2024) to 6.26 Cr., marking a decrease of 0.70 Cr..
• For Expenses, as of Mar 2025, the value is 5.16 Cr.. The value appears to be improving (decreasing) as expected. It has decreased from 5.38 Cr. (Sep 2024) to 5.16 Cr., marking a decrease of 0.22 Cr..
• For Operating Profit, as of Mar 2025, the value is 1.10 Cr.. The value appears to be declining and may need further review. It has decreased from 1.58 Cr. (Sep 2024) to 1.10 Cr., marking a decrease of 0.48 Cr..
• For OPM %, as of Mar 2025, the value is 17.57%. The value appears to be declining and may need further review. It has decreased from 22.70% (Sep 2024) to 17.57%, marking a decrease of 5.13%.
• For Other Income, as of Mar 2025, the value is 0.02 Cr.. The value appears to be declining and may need further review. It has decreased from 0.09 Cr. (Sep 2024) to 0.02 Cr., marking a decrease of 0.07 Cr..
• For Interest, as of Mar 2025, the value is 0.04 Cr.. The value appears to be improving (decreasing) as expected. It has decreased from 0.12 Cr. (Sep 2024) to 0.04 Cr., marking a decrease of 0.08 Cr..
• For Depreciation, as of Mar 2025, the value is 0.08 Cr.. The value appears to be increasing, which may not be favorable. It has increased from 0.06 Cr. (Sep 2024) to 0.08 Cr., marking an increase of 0.02 Cr..
• For Profit before tax, as of Mar 2025, the value is 1.00 Cr.. The value appears to be declining and may need further review. It has decreased from 1.49 Cr. (Sep 2024) to 1.00 Cr., marking a decrease of 0.49 Cr..
• For Tax %, as of Mar 2025, the value is 16.00%. The value appears to be improving (decreasing) as expected. It has decreased from 36.24% (Sep 2024) to 16.00%, marking a decrease of 20.24%.
• For Net Profit, as of Mar 2025, the value is 0.82 Cr.. The value appears to be declining and may need further review. It has decreased from 0.95 Cr. (Sep 2024) to 0.82 Cr., marking a decrease of 0.13 Cr..
• For EPS in Rs, as of Mar 2025, the value is 2.83. The value appears to be declining and may need further review. It has decreased from 3.31 (Sep 2024) to 2.83, marking a decrease of 0.48.

Overall, while many items appear to show a positive trend, any significant downward movement warrant further investigation.

Profit & Loss - Annual Report

Last Updated: November 15, 2025, 3:23 am

Growth

Last Updated: September 5, 2025, 3:26 pm

Cash Flow

Financial Efficiency Indicators

Share Holding Pattern

Key Financial Ratios

After reviewing the key financial ratios for Euphoria Infotech (India) Ltd, here is a detailed analysis based on the latest available data and recent trends:

• For FaceValue, as of Mar 25, the value is 10.00. This value is within the healthy range. There is no change compared to the previous period (Mar 24) which recorded 10.00.
• For Basic EPS (Rs.), as of Mar 25, the value is 6.12. This value is within the healthy range. It has increased from 4.38 (Mar 24) to 6.12, marking an increase of 1.74.
• For Diluted EPS (Rs.), as of Mar 25, the value is 6.12. This value is within the healthy range. It has increased from 4.38 (Mar 24) to 6.12, marking an increase of 1.74.
• For Cash EPS (Rs.), as of Mar 25, the value is 6.68. This value is within the healthy range. It has increased from 3.44 (Mar 24) to 6.68, marking an increase of 3.24.
• For Book Value[Excl.RevalReserv]/Share (Rs.), as of Mar 25, the value is 56.50. It has increased from 50.38 (Mar 24) to 56.50, marking an increase of 6.12.
• For Book Value[Incl.RevalReserv]/Share (Rs.), as of Mar 25, the value is 56.50. It has increased from 50.38 (Mar 24) to 56.50, marking an increase of 6.12.
• For Revenue From Operations / Share (Rs.), as of Mar 25, the value is 45.54. It has increased from 20.72 (Mar 24) to 45.54, marking an increase of 24.82.
• For PBDIT / Share (Rs.), as of Mar 25, the value is 9.62. This value is within the healthy range. It has increased from 5.31 (Mar 24) to 9.62, marking an increase of 4.31.
• For PBIT / Share (Rs.), as of Mar 25, the value is 9.11. This value is within the healthy range. It has increased from 5.07 (Mar 24) to 9.11, marking an increase of 4.04.
• For PBT / Share (Rs.), as of Mar 25, the value is 8.54. This value is within the healthy range. It has increased from 4.26 (Mar 24) to 8.54, marking an increase of 4.28.
• For Net Profit / Share (Rs.), as of Mar 25, the value is 6.17. This value is within the healthy range. It has increased from 3.19 (Mar 24) to 6.17, marking an increase of 2.98.
• For NP After MI And SOA / Share (Rs.), as of Mar 25, the value is 6.12. This value is within the healthy range. It has increased from 3.17 (Mar 24) to 6.12, marking an increase of 2.95.
• For PBDIT Margin (%), as of Mar 25, the value is 21.12. This value is within the healthy range. It has decreased from 25.63 (Mar 24) to 21.12, marking a decrease of 4.51.
• For PBIT Margin (%), as of Mar 25, the value is 19.99. This value is within the healthy range. It has decreased from 24.45 (Mar 24) to 19.99, marking a decrease of 4.46.
• For PBT Margin (%), as of Mar 25, the value is 18.75. This value is within the healthy range. It has decreased from 20.57 (Mar 24) to 18.75, marking a decrease of 1.82.
• For Net Profit Margin (%), as of Mar 25, the value is 13.55. This value exceeds the healthy maximum of 10. It has decreased from 15.39 (Mar 24) to 13.55, marking a decrease of 1.84.
• For NP After MI And SOA Margin (%), as of Mar 25, the value is 13.43. This value is within the healthy range. It has decreased from 15.29 (Mar 24) to 13.43, marking a decrease of 1.86.
• For Return on Networth / Equity (%), as of Mar 25, the value is 10.82. This value is below the healthy minimum of 15. It has increased from 6.29 (Mar 24) to 10.82, marking an increase of 4.53.
• For Return on Capital Employeed (%), as of Mar 25, the value is 15.18. This value is within the healthy range. It has increased from 9.73 (Mar 24) to 15.18, marking an increase of 5.45.
• For Return On Assets (%), as of Mar 25, the value is 9.17. This value is within the healthy range. It has increased from 5.51 (Mar 24) to 9.17, marking an increase of 3.66.
• For Long Term Debt / Equity (X), as of Mar 25, the value is 0.02. This value is below the healthy minimum of 0.2. There is no change compared to the previous period (Mar 24) which recorded 0.02.
• For Total Debt / Equity (X), as of Mar 25, the value is 0.07. This value is within the healthy range. It has increased from 0.06 (Mar 24) to 0.07, marking an increase of 0.01.
• For Asset Turnover Ratio (%), as of Mar 25, the value is 0.73. It has increased from 0.48 (Mar 24) to 0.73, marking an increase of 0.25.
• For Current Ratio (X), as of Mar 25, the value is 8.18. This value exceeds the healthy maximum of 3. It has decreased from 8.45 (Mar 24) to 8.18, marking a decrease of 0.27.
• For Quick Ratio (X), as of Mar 25, the value is 4.83. This value exceeds the healthy maximum of 2. It has decreased from 5.80 (Mar 24) to 4.83, marking a decrease of 0.97.
• For Inventory Turnover Ratio (X), as of Mar 25, the value is 2.47. This value is below the healthy minimum of 4. It has increased from 0.00 (Mar 24) to 2.47, marking an increase of 2.47.
• For Interest Coverage Ratio (X), as of Mar 25, the value is 17.00. This value is within the healthy range. It has increased from 6.61 (Mar 24) to 17.00, marking an increase of 10.39.
• For Interest Coverage Ratio (Post Tax) (X), as of Mar 25, the value is 11.91. This value is within the healthy range. It has increased from 4.97 (Mar 24) to 11.91, marking an increase of 6.94.
• For Enterprise Value (Cr.), as of Mar 25, the value is 12.45. It has decreased from 14.88 (Mar 24) to 12.45, marking a decrease of 2.43.
• For EV / Net Operating Revenue (X), as of Mar 25, the value is 0.94. This value is below the healthy minimum of 1. It has decreased from 2.47 (Mar 24) to 0.94, marking a decrease of 1.53.
• For EV / EBITDA (X), as of Mar 25, the value is 4.46. This value is below the healthy minimum of 5. It has decreased from 9.65 (Mar 24) to 4.46, marking a decrease of 5.19.
• For MarketCap / Net Operating Revenue (X), as of Mar 25, the value is 0.92. This value is below the healthy minimum of 1. It has decreased from 2.67 (Mar 24) to 0.92, marking a decrease of 1.75.
• For Price / BV (X), as of Mar 25, the value is 0.74. This value is below the healthy minimum of 1. It has decreased from 1.10 (Mar 24) to 0.74, marking a decrease of 0.36.
• For Price / Net Operating Revenue (X), as of Mar 25, the value is 0.92. This value is below the healthy minimum of 1. It has decreased from 2.67 (Mar 24) to 0.92, marking a decrease of 1.75.
• For EarningsYield, as of Mar 25, the value is 0.14. This value is below the healthy minimum of 5. It has increased from 0.05 (Mar 24) to 0.14, marking an increase of 0.09.

Overall, while many metrics show healthy performance, any figures highlighted in red or significant downward trends warrant further investigation.

Fair Value

*Investments are subject to market risks

Strength and Weakness